# REX Shares Launches REX Peptide ETF (PEPT) to Target Broader GLP-1 Supply Chain

- URL: https://stocks.freetheai.org/news/rex-shares-launches-rex-peptide-etf-pept-to-target-broader-glp-1-supply-chain-94023d
- Published: 2026-10-14T12:00:00Z
- Category: markets; sentiment: neutral; impact: low
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

REX Shares has launched the REX Peptide ETF (PEPT) on the Nasdaq stock exchange. The fund carries an expense ratio of 0.65% and tracks companies involved in the development, manufacturing, equipment, and commercialization of peptide therapies. It marks the fund issuer's third thematic strategy, joining earlier funds focused on drones and artificial intelligence chipmaking.

While investor attention in GLP-1 weight-loss and diabetes treatments has largely concentrated on major pharmaceutical firms like Eli Lilly and Novo Nordisk, the broader peptide sector relies on an extensive network of developers and supply chain partners. High demand for GLP-1 medications has created manufacturing capacity bottlenecks across the market. The new exchange-traded fund provides targeted exposure across the full production line, including therapeutics, specialized manufacturing tools, nutraceuticals, and skincare.

The fund tracks the VettaFi Peptide Index, which consists of 36 global companies, with U.S. businesses representing 52.9% of index weight and foreign companies making up the remaining 47.1%. Market participants will watch whether expanding manufacturing infrastructure across these holding companies helps drug developers resolve supply constraints and meet growing global demand for peptide-based treatments.

## Key points

- REX Shares launched the REX Peptide ETF (PEPT) on Nasdaq with an expense ratio of 0.65%.
- The fund tracks 36 global companies involved in developing, manufacturing, and commercializing peptide products.
- U.S. companies account for 52.9% of the underlying index weight, with non-U.S. firms making up 47.1%.
- Index constituents require a minimum market cap of $100 million and a $1 million three-month average daily trading value.

## Questions and answers

### What is the ticker symbol and expense ratio for the REX Peptide ETF?

The fund trades on Nasdaq under the ticker symbol PEPT and carries an expense ratio of 0.65%.

### What companies does the REX Peptide ETF hold?

The ETF holds 36 global companies spanning medicine development, manufacturing, delivery, nutraceuticals, and skincare within the peptide industry.

### How does the PEPT fund select its index constituents?

Eligible companies must have a market cap of at least $100 million and a $1 million daily trading volume, with at least 80% of index weight allocated to pure-play peptide firms.